Choosing an Assisted Reproduction Route in Bilateral Tubal Block
A 31-year-old woman has been trying to conceive for five years. Her cycles are regular, day-3 FSH and AMH are normal, and thyroid and prolactin values are within range. A hysterosalpingogram shows a normal uterine cavity but complete bilateral block of the fallopian tubes. Her husband's semen analysis, repeated twice, shows a count of 12 million/mL, 30% motility and 55% normal morphology. The couple is offered four options: intrauterine insemination (IUI), gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT) and in-vitro fertilisation with embryo transfer (IVF-ET). The husband prefers IUI because it is cheapest; his mother believes a 'test-tube baby' is grown entirely in the laboratory and will not be genetically theirs; the clinic advises IVF-ET. The couple can afford only one assisted cycle and cannot repeat treatment many times.
1. Evaluate all four options for this couple and identify which ones are ruled out by the tubal findings alone, with reasons.
Read the worked answer
The decisive anatomical fact is that both tubes are blocked, and three of the four procedures require a patent tube somewhere along the sperm–egg path.
IUI places washed sperm into the uterine cavity; fertilisation must then occur in the ampulla, so at least one open tube is essential. With 12 million/mL and 30% motility, the post-wash total motile count is also likely to be low, so IUI would be a poor choice even if the tubes were open.
GIFT retrieves oocytes and places them together with sperm into the fimbrial end of the tube; blocked tubes make this impossible.
ZIFT retrieves oocytes, allows fertilisation in the laboratory, and transfers the zygote into the tube - again impossible here.
IVF-ET is the only option that bypasses the tube entirely: oocytes are retrieved, fertilised in the laboratory, and the embryo is placed directly into the uterus. It therefore remains the rational choice, and the low cost of IUI does not compensate for a procedure that cannot work in this couple.
2. Outline what IVF-ET involves for this couple and decide whether ICSI should be planned from the start or held in reserve.
Read the worked answer
The cycle involves controlled ovarian stimulation with gonadotrophins and monitoring of follicle growth, an hCG trigger when follicles are mature, transvaginal oocyte retrieval about 34–36 hours later, fertilisation in vitro with prepared sperm, embryo culture for 3–5 days, intrauterine transfer of one or two embryos, and luteal-phase support.
The judgement call is fertilisation method. A count of 12 million/mL with 30% motility and 55% normal morphology is mild oligoasthenospermia, not severe. Conventional IVF, in which sperm are placed around the oocyte, should therefore give acceptable fertilisation, and ICSI adds cost and small technical risks without proven benefit in this category. The practical approach is to plan conventional IVF but check fertilisation on day 1; if fertilisation fails or is very poor, ICSI is used for the remaining oocytes or in a subsequent cycle. Committing the couple's single affordable cycle to ICSI would spend money that is better kept for embryo cryopreservation and transfer. Reserve ICSI for failure, or for a clear deterioration in semen parameters on the day of retrieval.
3. Correct the two misconceptions in the case - that IVF is chosen because it is cheapest, and that a 'test-tube baby' is grown entirely in the laboratory and is not the couple's genetic child.
Read the worked answer
Cost is not the deciding factor; feasibility is. IUI is cheaper per cycle but has a near-zero chance of success when both tubes are blocked, so the effective cost per pregnancy is far higher than that of IVF-ET. A cheaper treatment that cannot produce a pregnancy is not economical.
The 'test-tube' label describes only the first few days. The oocyte comes from the woman and the sperm from her husband, so the embryo is fully their genetic child. Fertilisation occurs in a dish, and the embryo is cultured only to about the 8-cell to blastocyst stage, roughly 3–5 days, before transfer into the woman's uterus. Implantation, placental development and the entire 9-month gestation occur inside her body; the laboratory does not gestate the baby.
A related point worth stating is that IVF-ET does not involve choosing or altering genes, so it is not 'designer baby' technology. Genetic parentage, pregnancy and delivery remain with the couple.